Danish-based Novo Nordisk unveiled its new U.S. headquarters in Plainsboro, New Jersey. The facility is the result of a $225 million redevelopment project which utilized an existing structure and sustainable materials to limit environmental impact.
"Becoming a leading healthcare company requires not only the best people in the field, but a work environment that fosters collaboration," said Jurek Gruhn, president of Novo Nordisk's U.S. business. "Our new home provides our employees with the physical space and resources to fuel our continued commitment to provide the best possible solutions for diabetes patients in the United States."
Reflecting Novo Nordisk's expectations for continued growth in the U.S., the company's initial plans are to occupy 75 percent of the building's total capacity, leaving room for future expansion, the company said. The redeveloped building was designed to promote innovation, teamwork, and employee wellness. Features include a state-of-the-art cafeteria, a one-mile scenic walking path, and special quiet focus areas where employees can work effectively.
Utilizing recycled and locally-sourced materials, the new U.S. headquarters is consistent with Novo Nordisk's Triple Bottom Line approach to business, company officials said.The LEED Silver certified campus is fully powered by renewable energy from wind, solar, and hydro sources – a feature that is expected to lead to a 30 percent reduction in energy costs.
"The completion of this project and launch of Novo Nordisk's new headquarters is a milestone in the long and proud history of the life sciences industry here in New Jersey," said Lt. Gov. Kim Guadagno. "We are gratified that this great global company has reaffirmed its belief that our state is an ideal location for a fast-growing, research-based business to plant its flag. The impact of Novo Nordisk's investment will continue well into the future as additional jobs are created for our skilled New Jersey workforce."
"As an employee of Novo Nordisk for 13 years, I've had a first-hand view of our remarkable evolution in the U.S.," said Jill Webb, senior director of medical information at Novo Nordisk. "I'm motivated daily by my colleagues and their dedication to improve patient well being – something that has never changed, even after 13 years. This new headquarters is an opportunity to make it even easier for employees to have a direct impact on driving Novo Nordisk's leadership."